1. Home
  2. IVA vs SMHI Comparison

IVA vs SMHI Comparison

Compare IVA & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
    SELLHOLDBUYas of 6 hours ago
  • SMHI
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • IVA 2011
  • SMHI 1989
  • Country
  • IVA France
  • SMHI United States
  • Employees
  • IVA N/A
  • SMHI N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • SMHI Marine Transportation
  • Sector
  • IVA Health Care
  • SMHI Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • SMHI Nasdaq
  • Market Cap
  • IVA 162.8M
  • SMHI 142.2M
  • IPO Year
  • IVA 2020
  • SMHI N/A
  • Fundamental
  • Price
  • IVA $2.94
  • SMHI $4.99
  • Analyst Decision
  • IVA Strong Buy
  • SMHI
  • Analyst Count
  • IVA 4
  • SMHI 0
  • Target Price
  • IVA $13.25
  • SMHI N/A
  • AVG Volume (30 Days)
  • IVA 7.6K
  • SMHI 106.6K
  • Earning Date
  • IVA 03-26-2025
  • SMHI 04-30-2025
  • Dividend Yield
  • IVA N/A
  • SMHI N/A
  • EPS Growth
  • IVA N/A
  • SMHI N/A
  • EPS
  • IVA N/A
  • SMHI N/A
  • Revenue
  • IVA $15,243,814.00
  • SMHI $271,361,000.00
  • Revenue This Year
  • IVA $18.05
  • SMHI $8.07
  • Revenue Next Year
  • IVA $46.74
  • SMHI $7.29
  • P/E Ratio
  • IVA N/A
  • SMHI N/A
  • Revenue Growth
  • IVA N/A
  • SMHI N/A
  • 52 Week Low
  • IVA $1.53
  • SMHI $4.75
  • 52 Week High
  • IVA $3.98
  • SMHI $15.36
  • Technical
  • Relative Strength Index (RSI)
  • IVA 52.48
  • SMHI 34.90
  • Support Level
  • IVA $2.88
  • SMHI $4.80
  • Resistance Level
  • IVA $3.10
  • SMHI $5.37
  • Average True Range (ATR)
  • IVA 0.18
  • SMHI 0.26
  • MACD
  • IVA -0.02
  • SMHI 0.03
  • Stochastic Oscillator
  • IVA 54.55
  • SMHI 26.67

Stock Price Comparison Chart: IVA vs SMHI

IVA
SMHI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0246810121416IVA VS SMHI

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use